Global Nosocomial Infection Treatment Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Nosocomial Infection Treatment Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Antibacterial Treatment
  • 1.4.3 Antiviral Treatment
  • 1.4.4 Antifungal Treatment
• 1.5 Market by Application
  • 1.5.1 Global Nosocomial Infection Treatment Market Share by Application (2019-2025)
  • 1.5.2 Ventilator Associated Pneumonia
  • 1.5.3 Urinary Tract Infection
  • 1.5.4 Blood Stream Infection
  • 1.5.5 Surgical Site Infection
  • 1.5.6 Gastrointestinal Infection
  • 1.5.7 MRSA
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Nosocomial Infection Treatment Market Size
• 2.2 Nosocomial Infection Treatment Growth Trends by Regions
  • 2.2.1 Nosocomial Infection Treatment Market Size by Regions (2019-2025)
  • 2.2.2 Nosocomial Infection Treatment Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Nosocomial Infection Treatment Market Size by by Players
  • 3.1.1 Global Nosocomial Infection Treatment Revenue by by Players (2014-2019)
  • 3.1.2 Global Nosocomial Infection Treatment Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Nosocomial Infection Treatment Market Concentration Ratio (CR5 and HHI)
• 3.2 Nosocomial Infection Treatment Key Players Head office and Area Served
• 3.3 Key Players Nosocomial Infection Treatment Product/Solution/Service
• 3.4 Date of Enter into Nosocomial Infection Treatment Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Nosocomial Infection Treatment Market Size by Type (2014-2019)
• 4.2 Global Nosocomial Infection Treatment Market Size by Application (2014-2019)

5 North America

• 5.1 North America Nosocomial Infection Treatment Market Size (2014-2019)
• 5.2 Nosocomial Infection Treatment Key Players in North America
• 5.3 North America Nosocomial Infection Treatment Market Size by Type
• 5.4 North America Nosocomial Infection Treatment Market Size by Application

6 Europe

• 6.1 Europe Nosocomial Infection Treatment Market Size (2014-2019)
• 6.2 Nosocomial Infection Treatment Key Players in Europe
• 6.3 Europe Nosocomial Infection Treatment Market Size by Type
• 6.4 Europe Nosocomial Infection Treatment Market Size by Application

7 China

• 7.1 China Nosocomial Infection Treatment Market Size (2014-2019)
• 7.2 Nosocomial Infection Treatment Key Players in China
• 7.3 China Nosocomial Infection Treatment Market Size by Type
• 7.4 China Nosocomial Infection Treatment Market Size by Application

8 Japan

• 8.1 Japan Nosocomial Infection Treatment Market Size (2014-2019)
• 8.2 Nosocomial Infection Treatment Key Players in Japan
• 8.3 Japan Nosocomial Infection Treatment Market Size by Type
• 8.4 Japan Nosocomial Infection Treatment Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Nosocomial Infection Treatment Market Size (2014-2019)
• 9.2 Nosocomial Infection Treatment Key Players in Southeast Asia
• 9.3 Southeast Asia Nosocomial Infection Treatment Market Size by Type
• 9.4 Southeast Asia Nosocomial Infection Treatment Market Size by Application

10 India

• 10.1 India Nosocomial Infection Treatment Market Size (2014-2019)
• 10.2 Nosocomial Infection Treatment Key Players in India
• 10.3 India Nosocomial Infection Treatment Market Size by Type
• 10.4 India Nosocomial Infection Treatment Market Size by Application

11 Central & South America

• 11.1 Central & South America Nosocomial Infection Treatment Market Size (2014-2019)
• 11.2 Nosocomial Infection Treatment Key Players in Central & South America
• 11.3 Central & South America Nosocomial Infection Treatment Market Size by Type
• 11.4 Central & South America Nosocomial Infection Treatment Market Size by Application

12 International Players Profiles

• 12.1 Abbott
  • 12.1.1 Abbott Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Nosocomial Infection Treatment Introduction
  • 12.1.4 Abbott Revenue in Nosocomial Infection Treatment Business (2014-2019))
  • 12.1.5 Abbott Recent Development
• 12.2 Bayer
  • 12.2.1 Bayer Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Nosocomial Infection Treatment Introduction
  • 12.2.4 Bayer Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.2.5 Bayer Recent Development
• 12.3 Becton, Dickinson and Company
  • 12.3.1 Becton, Dickinson and Company Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Nosocomial Infection Treatment Introduction
  • 12.3.4 Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.3.5 Becton, Dickinson and Company Recent Development
• 12.4 Belimed
  • 12.4.1 Belimed Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Nosocomial Infection Treatment Introduction
  • 12.4.4 Belimed Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.4.5 Belimed Recent Development
• 12.5 BioMerieux
  • 12.5.1 BioMerieux Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Nosocomial Infection Treatment Introduction
  • 12.5.4 BioMerieux Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.5.5 BioMerieux Recent Development
• 12.6 Cantel
  • 12.6.1 Cantel Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Nosocomial Infection Treatment Introduction
  • 12.6.4 Cantel Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.6.5 Cantel Recent Development
• 12.7 Cepheid
  • 12.7.1 Cepheid Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Nosocomial Infection Treatment Introduction
  • 12.7.4 Cepheid Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.7.5 Cepheid Recent Development
• 12.8 Getinge Group
  • 12.8.1 Getinge Group Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Nosocomial Infection Treatment Introduction
  • 12.8.4 Getinge Group Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.8.5 Getinge Group Recent Development
• 12.9 Kimberly-Clark Corp.
  • 12.9.1 Kimberly-Clark Corp. Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Nosocomial Infection Treatment Introduction
  • 12.9.4 Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.9.5 Kimberly-Clark Corp. Recent Development
• 12.10 Merck & Co
  • 12.10.1 Merck & Co Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Nosocomial Infection Treatment Introduction
  • 12.10.4 Merck & Co Revenue in Nosocomial Infection Treatment Business (2014-2019)
  • 12.10.5 Merck & Co Recent Development
• 12.11 Nordion
• 12.12 Pfizer
• 12.13 Roche
• 12.14 Sakura Seiki
• 12.15 BioMérieux
• 12.16 Steris
• 12.17 Johnson & Johnson
• 12.18 Sterigenics International, Inc.
• 12.19 Halyard Health, Inc.
• 12.20 Advanced Sterilization Products
• 12.21 Matachana Group

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer